163 related articles for article (PubMed ID: 30851880)
1. Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation.
Boogerd LSF; Boonstra MC; Prevoo HAJM; Handgraaf HJM; Kuppen PJK; van de Velde CJH; Fish A; Cordfunke RA; Valentijn ARPM; Terwisscha van Scheltinga AG; MacDonald GC; Cizeau J; Premsukh A; Vinkenburg van Slooten ML; Burggraaf J; Sier CFM; Vahrmeijer AL
Surg Oncol; 2019 Mar; 28():1-8. PubMed ID: 30851880
[TBL] [Abstract][Full Text] [Related]
2. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.
van Driel PB; Boonstra MC; Prevoo HA; van de Giessen M; Snoeks TJ; Tummers QR; Keereweer S; Cordfunke RA; Fish A; van Eendenburg JD; Lelieveldt BP; Dijkstra J; van de Velde CJ; Kuppen PJ; Vahrmeijer AL; Löwik CW; Sier CF
BMC Cancer; 2016 Nov; 16(1):884. PubMed ID: 27842504
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.
Houvast RD; Badr N; March T; de Muynck LDAN; Sier VQ; Schomann T; Bhairosingh S; Baart VM; Peeters JAHM; van Westen GJP; Plückthun A; Burggraaf J; Kuppen PJK; Vahrmeijer AL; Sier CFM
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2179-2192. PubMed ID: 37642704
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAM.
Warnders FJ; Waaijer SJ; Pool M; Lub-de Hooge MN; Friedrich M; Terwisscha van Scheltinga AG; Deegen P; Stienen SK; Pieslor PC; Cheung HK; Kosterink JG; de Vries EG
J Nucl Med; 2016 May; 57(5):812-7. PubMed ID: 26848172
[TBL] [Abstract][Full Text] [Related]
6. Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types.
Handgraaf HJM; Boonstra MC; Prevoo HAJM; Kuil J; Bordo MW; Boogerd LSF; Sibinga Mulder BG; Sier CFM; Vinkenburg-van Slooten ML; Valentijn ARPM; Burggraaf J; van de Velde CJH; Frangioni JV; Vahrmeijer AL
Oncotarget; 2017 Mar; 8(13):21054-21066. PubMed ID: 28416744
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts.
El-Sayed A; Bernhard W; Barreto K; Gonzalez C; Hill W; Pastushok L; Fonge H; Geyer CR
Theranostics; 2018; 8(17):4856-4869. PubMed ID: 30279742
[No Abstract] [Full Text] [Related]
8. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
Tang C; Du Y; Liang Q; Cheng Z; Tian J
Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
[TBL] [Abstract][Full Text] [Related]
9. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
[TBL] [Abstract][Full Text] [Related]
11. Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery.
Kijanka M; Warnders FJ; El Khattabi M; Lub-de Hooge M; van Dam GM; Ntziachristos V; de Vries L; Oliveira S; van Bergen En Henegouwen PM
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1718-29. PubMed ID: 23778558
[TBL] [Abstract][Full Text] [Related]
12. uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.
Boonstra MC; van Driel PB; van Willigen DM; Stammes MA; Prevoo HA; Tummers QR; Mazar AP; Beekman FJ; Kuppen PJ; van de Velde CJ; Löwik CW; Frangioni JV; van Leeuwen FW; Sier CF; Vahrmeijer AL
Oncotarget; 2015 Jun; 6(16):14260-73. PubMed ID: 25895028
[TBL] [Abstract][Full Text] [Related]
13. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
[TBL] [Abstract][Full Text] [Related]
14. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma.
Baart VM; van der Horst G; Deken MM; Bhairosingh SS; Schomann T; Sier VQ; van der Mark MH; Iamele L; de Jonge H; Resnati M; Mazar AP; Pelger RCM; van der Pluijm G; Kuppen PJK; Vahrmeijer AL; Sier CFM
Eur J Cancer; 2021 Mar; 146():11-20. PubMed ID: 33561783
[TBL] [Abstract][Full Text] [Related]
15. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
16. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
[TBL] [Abstract][Full Text] [Related]
17. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
[TBL] [Abstract][Full Text] [Related]
18. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
19. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M
J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946
[TBL] [Abstract][Full Text] [Related]
20. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
